Ranibizumab for Age-Related Macular Degeneration

被引：0
作者：
Cheng, Jin-Wei [1 ]
Wei, Rui-Li [1 ]
机构：
[1] Second Mil Med Univ, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：582 / 582
页数：1
相关论文
共 3 条
[1]   Severe Intraocular Inflammation after Intravitreal Injection of Bevacizumab [J].
Sato, Tatsuhiko ;
Emi, Kazuyuki ;
Ikeda, Toshihide ;
Bando, Hajime ;
Sato, Shigeru ;
Morita, Shin-ichi ;
Oyagi, Tomohito ;
Sawada, Kosaku .
OPHTHALMOLOGY, 2010, 117 (03) :512-U132
[2]   Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial [J].
Subramanian, M. L. ;
Abedi, G. ;
Ness, S. ;
Ahmed, E. ;
Fenberg, M. ;
Daly, M. K. ;
Houranieh, A. ;
Feinberg, E. B. .
EYE, 2010, 24 (11) :1708-1715
[3]   Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study [J].
Tufail, Adnan ;
Patel, Praveen J. ;
Egan, Catherine ;
Hykin, Philip ;
da Cruz, Lyndon ;
Gregor, Zdenek ;
Dowler, Jonathan ;
Majid, Mohammed A. ;
Bailey, Clare ;
Mohamed, Quresh ;
Johnston, Robert ;
Bunce, Catey ;
Xing, Wen .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :1398
1